CN Patent

CN116801869A — 左旋多巴给药方案

Assigned to Anmuni Pharmaceutical Co · Expires 2023-09-22 · 3y expired

What this patent protects

本发明提供了用于治疗帕金森病患者的控释左旋多巴组合物的口服给药方案。

USPTO Abstract

本发明提供了用于治疗帕金森病患者的控释左旋多巴组合物的口服给药方案。

Drugs covered by this patent

Patent Metadata

Patent number
CN116801869A
Jurisdiction
CN
Classification
—
Expires
2023-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Anmuni Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.